162 related articles for article (PubMed ID: 33051435)
1. CB13, a novel PPARγ ligand, overcomes radio-resistance via ROS generation and ER stress in human non-small cell lung cancer.
Kim TW; Hong DW; Hong SH
Cell Death Dis; 2020 Oct; 11(10):848. PubMed ID: 33051435
[TBL] [Abstract][Full Text] [Related]
2. CB11, a novel purine-based PPARɣ ligand, overcomes radio-resistance by regulating ATM signalling and EMT in human non-small-cell lung cancer cells.
Kim TW; Hong DW; Park JW; Hong SH
Br J Cancer; 2020 Dec; 123(12):1737-1748. PubMed ID: 32958825
[TBL] [Abstract][Full Text] [Related]
3. Combined treatment with peroxisome proliferator-activated receptor (PPAR) gamma ligands and gamma radiation induces apoptosis by PPARγ-independent up-regulation of reactive oxygen species-induced deoxyribonucleic acid damage signals in non-small cell lung cancer cells.
Han EJ; Im CN; Park SH; Moon EY; Hong SH
Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):e239-48. PubMed ID: 23332223
[TBL] [Abstract][Full Text] [Related]
4. A novel PPARɣ ligand, PPZ023, overcomes radioresistance via ER stress and cell death in human non-small-cell lung cancer cells.
Kim TW; Hong DW; Kang CM; Hong SH
Exp Mol Med; 2020 Oct; 52(10):1730-1743. PubMed ID: 33046822
[TBL] [Abstract][Full Text] [Related]
5. Apoptotic action of peroxisome proliferator-activated receptor-gamma activation in human non small-cell lung cancer is mediated via proline oxidase-induced reactive oxygen species formation.
Kim KY; Ahn JH; Cheon HG
Mol Pharmacol; 2007 Sep; 72(3):674-85. PubMed ID: 17535976
[TBL] [Abstract][Full Text] [Related]
6. Up-regulation of p21 gene expression by peroxisome proliferator-activated receptor gamma in human lung carcinoma cells.
Han S; Sidell N; Fisher PB; Roman J
Clin Cancer Res; 2004 Mar; 10(6):1911-9. PubMed ID: 15041706
[TBL] [Abstract][Full Text] [Related]
7. Roles of peroxisome proliferator-activated receptor-alpha and -gamma in the development of non-small cell lung cancer.
Li MY; Yuan H; Ma LT; Kong AW; Hsin MK; Yip JH; Underwood MJ; Chen GG
Am J Respir Cell Mol Biol; 2010 Dec; 43(6):674-83. PubMed ID: 20081051
[TBL] [Abstract][Full Text] [Related]
8. Uncoupling protein 2 downregulation by hypoxia through repression of peroxisome proliferator-activated receptor γ promotes chemoresistance of non-small cell lung cancer.
Wang M; Li G; Yang Z; Wang L; Zhang L; Wang T; Zhang Y; Zhang S; Han Y; Jia L
Oncotarget; 2017 Jan; 8(5):8083-8094. PubMed ID: 28042952
[TBL] [Abstract][Full Text] [Related]
9. Bexarotene inhibits the viability of non-small cell lung cancer cells via slc10a2/PPARγ/PTEN/mTOR signaling pathway.
Ai X; Mao F; Shen S; Shentu Y; Wang J; Lu S
BMC Cancer; 2018 Apr; 18(1):407. PubMed ID: 29642873
[TBL] [Abstract][Full Text] [Related]
10. Peroxisome proliferator-activated receptor-gamma ligands suppress fibronectin gene expression in human lung carcinoma cells: involvement of both CRE and Sp1.
Han S; Ritzenthaler JD; Rivera HN; Roman J
Am J Physiol Lung Cell Mol Physiol; 2005 Sep; 289(3):L419-28. PubMed ID: 15908479
[TBL] [Abstract][Full Text] [Related]
11. Induction of apoptosis by 15d-PGJ2 via ROS formation: an alternative pathway without PPARγ activation in non-small cell lung carcinoma A549 cells.
Wang JJ; Mak OT
Prostaglandins Other Lipid Mediat; 2011 Apr; 94(3-4):104-11. PubMed ID: 21396480
[TBL] [Abstract][Full Text] [Related]
12. Activation of peroxisome proliferator-activated receptor-gamma (PPARgamma) induces cell death through MAPK-dependent mechanism in osteoblastic cells.
Kim SH; Yoo CI; Kim HT; Park JY; Kwon CH; Kim YK
Toxicol Appl Pharmacol; 2006 Sep; 215(2):198-207. PubMed ID: 16616945
[TBL] [Abstract][Full Text] [Related]
13. β-Apopicropodophyllin functions as a radiosensitizer targeting ER stress in non-small cell lung cancer.
Kim JY; Cho JH; Kim EM; Shin HJ; Hwang SG; Song JY; Um HD; Park JK
Biomed Pharmacother; 2019 May; 113():108769. PubMed ID: 30870718
[TBL] [Abstract][Full Text] [Related]
14. PPARgamma agonists sensitize PTEN-deficient resistant lung cancer cells to EGFR tyrosine kinase inhibitors by inducing autophagy.
To KKW; Wu WKK; Loong HHF
Eur J Pharmacol; 2018 Mar; 823():19-26. PubMed ID: 29378193
[TBL] [Abstract][Full Text] [Related]
15. PB01 suppresses radio-resistance by regulating ATR signaling in human non-small-cell lung cancer cells.
Kim TW; Hong DW; Hong SH
Sci Rep; 2021 Jun; 11(1):12093. PubMed ID: 34103635
[TBL] [Abstract][Full Text] [Related]
16. Bavachinin exhibits antitumor activity against non‑small cell lung cancer by targeting PPARγ.
Ge LN; Yan L; Li C; Cheng K
Mol Med Rep; 2019 Sep; 20(3):2805-2811. PubMed ID: 31322235
[TBL] [Abstract][Full Text] [Related]
17. Combination treatment with erlotinib and ampelopsin overcomes erlotinib resistance in NSCLC cells via the Nox2-ROS-Bim pathway.
Hong SW; Park NS; Noh MH; Shim JA; Ahn BN; Kim YS; Kim D; Lee HK; Hur DY
Lung Cancer; 2017 Apr; 106():115-124. PubMed ID: 28285685
[TBL] [Abstract][Full Text] [Related]
18. Combined treatment with the Cox-2 inhibitor niflumic acid and PPARγ ligand ciglitazone induces ER stress/caspase-8-mediated apoptosis in human lung cancer cells.
Kim BM; Maeng K; Lee KH; Hong SH
Cancer Lett; 2011 Jan; 300(2):134-44. PubMed ID: 21067863
[TBL] [Abstract][Full Text] [Related]
19. Selective activation of PPARgamma in breast, colon, and lung cancer cell lines.
Allred CD; Kilgore MW
Mol Cell Endocrinol; 2005 May; 235(1-2):21-9. PubMed ID: 15866424
[TBL] [Abstract][Full Text] [Related]
20. Peroxisome proliferator-activated receptor-gamma ligands inhibit alpha5 integrin gene transcription in non-small cell lung carcinoma cells.
Han S; Rivera HN; Roman J
Am J Respir Cell Mol Biol; 2005 Apr; 32(4):350-9. PubMed ID: 15677767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
